Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
FDA approval of Azacitidine for continued treatment (maintenance) of adult patients with Acute myeloid leukemia (AML) who achieved complete remission (CR) or CR with incomplete blood count recovery (CRi) after intensive induction chemotherapy and are unable to complete intensive curative therapy (1, 4, 5, 6)
EMA approval for treatment of adult patients not eligible for HSCT with intermediate‑2 and high‑risk MDS (IPSS), CMML with 10–29% marrow blasts without myeloproliferative disorder, AML with 20–30% blasts and multilineage dysplasia, AML with >30% ma…